Article content
TORONTO, June 23, 2025 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding a total of 276,989,452 common shares of the Company voted in person or by proxy, representing 71.87% of the total number of common shares of the Company outstanding.
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
Each of the directors listed as a nominee in the Company’s definitive proxy statement dated April 25, 2025 was elected as a director of the Company, with each director receiving in excess of 92.3% of the votes cast in favor of his or her election. The detailed results of the vote for the election of directors are as follows:
Article content
Article content
Article content
Name of Director | Number of Shares Voted For | Percentage of Shares Voted For | Number of Shares Withheld from Voting | Percentage of Shares Withheld from Voting |
Michael Gorenstein | 206,219,875 | 92.38% | 17,012,443 | 7.62% |
Jason Adler | 215,665,946 | 96.61% | 7,566,372 | 3.39% |
Murray Garnick | 215,548,312 | 96.56% | 7,684,006 | 3.44% |
Kamran Khan | 216,349,694 | 96.92% | 6,882,624 | 3.08% |
Dominik Meier | 216,404,347 | 96.94% | 6,827,971 | 3.06% |
Elizabeth Seegar | 211,177,232 | 94.60% | 12,055,086 | 5.40% |
James Rudyk | 215,956,203 | 96.74% | 7,276,115 | 3.26% |
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
Shareholders also approved an advisory (non-binding) resolution on the compensation of the Company’s named executive officers, with 94.13% of votes cast in favor of such resolution, and approved the appointment of Davidson & Company LLP as the Company’s independent auditor for fiscal year 2025 and authorized the Board of Directors of the Company to fix the independent auditor’s remuneration.
Article content
For complete results on all matters voted on at the Meeting, please see the Report of Voting Results filed on the Company’s SEDAR+ profile at www.sedarplus.com and the Company’s Form 8-K filed on EDGAR at www.sec.gov/edgar.
Article content
Article content
About Cronos
Article content
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.
Article content
For further information, please contact:
Harrison Aaron
Investor Relations
Tel: (416) 504-0004
[email protected]
Article content
Article content
Article content
Article content
Article content
Article content